- This event has passed.
NFCR
Jan 11 • 8:10 AM
The 100 Most Influential CEOs in Oncology in 2025 (Full List)
"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing
TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC
CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer
Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera
CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma
Highlights from ASCO GI 2026 by Wafik El-Deiry
Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma
